Age-related microglial activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurodegeneration in C57BL/6 mice

Brain Research

Volumn 964, Issue 2, 2003, Pages 288-294

  Sugama, Shuei ^a,b   Yang, Lichuan ^c   Cho, Byung Pil ^b   DeGiorgio, Lorraine A ^b   Lorenzl, Stefan ^c   Albers, David S ^c   Beal, M Flint ^c   Volpe, Bruce T ^b   Joh, Tong H ^b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b BURKE MEDICAL RESEARCH INSTITUTE   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

C57BL 6 mouse; Dopaminergic neurodegeneration; Microglial activation; MPTP

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; TYROSINE 3 MONOOXYGENASE;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEPTH STIMULATION; CELL ACTIVATION; CELL LOSS; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; MOUSE; MOUSE STRAIN; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

EID: 0037469952     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)04085-4     Document Type: Article

References (53)

1. Adayev T., Estephan R., Meserole S., Mazza B., Yurkow E.J., Banerjee P. Externalization of phosphatidylserine may not be an early signal of apoptosis in neuronal cells, but only the phosphatidylserine-displaying apoptotic cells are phagocytosed by microglia. J. Neurochem. 71:1998;1854-1864.
2. Ali S.F., David S.N., Newport G.D., Cadet J.L., Slikker W. Jr. MPTP-induced oxidative stress and neurotoxicity are age-dependent: evidence from measures of reactive oxygen species and striatal dopamine levels. Synapse. 18:1994;27-34.
3. Banati R.B., Goerres G.W., Myers R., Gunn R.N., Turkheimer F.E., Kreutzberg G.W., Brooks D.J., Jones T., Duncan J.S. [11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen's encephalitis. Neurology. 53:1999;2199-2203.
4. Barger S.W., Chavis J.A., Drew P.D. Dehydroepiandrosterone inhibits microglial nitric oxide production in a stimulus-specific manner. J. Neurosci. Res. 62:2000;503-509.
5. Blum D., Torch S., Lambeng N., Nissou M., Benabid A.L., Sadoul R., Verna J.M. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog. Neurobiol. 65:2001;135-172.
6. Cho S., Kim Y., Cruz M.O., Park E.M., Chu C.K., Song G.Y., Joh T.H. Repression of proinflammatory cytokine and inducible nitric oxide synthase (NOS2) gene expression in activated microglia by N-acetyl-O-methyldopamine: protein kinase A-dependent mechanism. Glia. 33:2001;324-333.
7. Coggeshall R.E. A consideration of neural counting methods. Trends Neurosci. 15:1992;9-13.
8. Coyle J.T., Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science. 262:1993;689-695.
9. Czlonkowska A., Kohutnicka M., Kurkowska-Jastrzebska I., Czlonkowski A. Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson's disease mice model. Neurodegeneration. 5:1996;137-143.
10. Date I., Felten S.Y., Olschowka J.A., Felten D.L. Limited recovery of striatal dopaminergic fibers by adrenal medullary grafts in MPTP-treated aging mice. Exp. Neurol. 107:1990;197-207.
11. DeGiorgio L.A., Dibinis C., Milner T.A., Saji M., Volpe B.T. Histological and temporal characteristics of nigral transneuronal degeneration after striatal injury. Brain Res. 795:1998;1-9.
12. Desai V.G., Feuers R.J., Hart R.W., Ali S.F. MPP(+)-induced neurotoxicity in mouse is age-dependent: evidenced by the selective inhibition of complexes of electron transport. Brain Res. 715:1996;1-8.
13. Desole M.S., Esposito G., Enrico P., Miele M., Fresu L., De Natale G., Miele E., Grella G. Effects of ageing on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxic effects on striatum and brainstem in the rat. Neurosci. Lett. 159:1993;143-146.
14. Dickson D.W., Lee S.C., Mattiace L.A., Yen S.H., Brosnan C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia. 7:1993;75-83.
15. Fahn S., Cohen G. The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann. Neurol. 32:1992;804-812.
16. Graeber M.B., Bise K., Mehraein P. CR3/43, a marker for activated human microglia: application to diagnostic neuropathology. Neuropathol. Appl. Neurobiol. 20:1994;406-408.
17. Gregory C.D. CD14-dependent clearance of apoptotic cells: relevance to the immune system. Curr. Opin. Immunol. 12:2000;27-34.
18. Grunblatt E., Mandel S., Youdim M.B. Neuroprotective strategies in Parkinson's disease using the models of 6-hydroxydopamine and MPTP. Ann. NY Acad. Sci. 899:2000;262-273.
19. Gundersen H.J. Stereology: the fast lane between neuroanatomy and brain function - or still only a tightrope? Acta Neurol. Scand. Suppl. 137:1992;8-13.
20. Hartmann A., Hunot S., Michel P.P., Muriel M.P., Vyas S., Faucheux B.A., Mouatt-Prigent A., Turmel H., Srinivasan A., Ruberg M., Evan G.I., Agid Y., Hirsch E.C. Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. Proc. Natl. Acad. Sci. USA. 97:2000;2875-2880.
21. He Y., Appel S., Le W. Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum. Brain Res. 909:2001;187-193.
22. Herrero M.T., Hirsch E.C., Kastner A., Ruberg M., Luquin M.R., Laguna J., Javoy-Agid F., Obeso J.A., Agid Y. Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP? Neuroscience. 56:1993;499-511.
23. Irwin I., Finnegan K.T., Delanney L.E., Di Monte D., Langston J.W. The relationships between aging, monoamine oxidase, striatal dopamine and the effects of MPTP in C57BL/6 mice: a critical reassessment. Brain Res. 572:1992;224-231.
24. Kohutnicka M., Lewandowska E., Kurkowska-Jastrzebska I., Czlonkowski A., Czlonkowska A. Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Immunopharmacology. 39:1998;167-180.
25. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19:1996;312-318.
26. Kurkowska-Jastrzebska I., Wronska A., Kohutnicka M., Czlonkowski A., Czlonkowska A. The inflammatory reaction following 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine intoxication in mouse. Exp. Neurol. 156:1999;50-61.
27. Langston J.W. MPTP neurotoxicity: an overview and characterization of phases of toxicity. Life Sci. 36:1985;201-206.
28. Lim G.P., Chu T., Yang F., Beech W., Frautschy S.A., Cole G.M. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J. Neurosci. 21:2001;8370-8377.
29. McGeer P.L., Itagaki S., Boyes B.E., McGeer E.G. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology. 38:1988;1285-1291.
30. Mrak R.E., Griffin W.S. The role of chronic self-propagating glial responses in neurodegeneration: implications for long-lived survivors of human immunodeficiency virus. J. Neurovirol. 3:1997;241-246.
31. Mrak R.E., Griffin S.T., Graham D.I. Aging-associated changes in human brain. J. Neuropathol. Exp. Neurol. 56:1997;1269-1275.
32. Nishi K. Expression of c-Jun in dopaminergic neurons of the substantia nigra in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice. Brain Res. 771:1997;133-141.
33. Olanow C.W. A radical hypothesis for neurodegeneration. Trends Neurosci. 16:1993;439-444.
34. Ricaurte G.A., Langston J.W., Delanney L.E., Irwin I., Peroutka S.J., Forno L.S. Fate of nigrostriatal neurons in young mature mice given 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: a neurochemical and morphological reassessment. Brain Res. 376:1986;117-124.
35. Ricaurte G.A., DeLanney L.E., Irwin I., Langston J.W. Older dopaminergic neurons do not recover from the effects of MPTP. Neuropharmacology. 26:1987;97-99.
36. Ricaurte G.A., Irwin I., Forno L.S., DeLanney L.E., Langston E., Langston J.W. Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra. Brain Res. 403:1987;43-51.
37. Rogers J., Luber-Narod J., Styren S.D., Civin W.H. Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer's disease. Neurobiol. Aging. 9:1988;339-349.
38. Roth G.S., Lane M.A., Ingram D.K., Mattison J.A., Elahi D., Tobin J.D., Muller D., Metter E.J. Biomarkers of caloric restriction may predict longevity in humans. Science. 297:2002;811.
39. Rozovsky I., Finch C.E., Morgan T.E. Age-related activation of microglia and astrocytes: in vitro studies show persistent phenotypes of aging, increased proliferation, and resistance to down-regulation. Neurobiol. Aging. 19:1998;97-103.
40. Saji M., Cohen M., Blau A.D., Wessel T.C., Volpe B.T. Transient forebrain ischemia induces delayed injury in the substantia nigra reticulata: degeneration of GABA neurons, compensatory expression of GAD mRNA. Brain Res. 643:1994;234-244.
41. Savill J., Fadok V. Corpse clearance defines the meaning of cell death. Nature. 407:2000;784-788.
42. Singer T.P., Ramsay R.R. Mechanism of the neurotoxicity of MPTP. An update, FEBS Lett. 274:1990;1-8.
43. Smeyne M., Goloubeva O., Smeyne R.J. Strain-dependent susceptibility to MPTP and MPP(+)-induced parkinsonism is determined by glia. Glia. 34:2001;73-80.
44. S. Sugama, B.P. Cho, L.A. DeGiorgio, Y. Shimizu, S.S. Kim, Y.S. Kim, D.H. Shin, B.T. Volpe, D.J. Reis, S. Cho, T.H. Joh, Temporal and sequential analysis of microglia in the substantia nigra following medial forebrain bundle axotomy in rat, Neuroscience (2002) in press.
45. Tomas-Camardiel M., Sanchez-Hidalgo M.C., Sanchez del Pino M.J., Navarro A., Machado A., Cano J. Comparative study of the neuroprotective effect of dehydroepiandrosterone and 17beta-estradiol against 1-methyl-4-phenylpyridium toxicity on rat striatum. Neuroscience. 109:2002;569-584.
46. Turmel H., Hartmann A., Parain K., Douhou A., Srinivasan A., Agid Y., Hirsch E.C. Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice. Mov. Disord. 16:2001;185-189.
47. Volpe B.T., Blau A.D., Wessel T.C., Saji M. Delayed histopathological neuronal damage in the substantia nigra compacta (nucleus A9) after transient forebrain ischaemia. Neurobiol. Dis. 2:1995;119-127.
48. Volpe B.T., Wildmann J., Altar C.A. Brain-derived neurotrophic factor prevents the loss of nigral neurons induced by excitotoxic striatal-pallidal lesions. Neuroscience. 83:1998;741-748.
49. Walsh S.L., Wagner G.C. Age-dependent effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): correlation with monoamine oxidase-B. Synapse. 3:1989;308-314.
50. Wang M.J., Huang H.M., Chen H.L., Kuo J.S., Jeng K.C. Dehydroepiandrosterone inhibits lipopolysaccharide-induced nitric oxide production in BV-2 microglia. J. Neurochem. 77:2001;830-838.
51. Witting A., Muller P., Herrmann A., Kettenmann H., Nolte C. Phagocytic clearance of apoptotic neurons by Microglia/Brain macrophages in vitro: involvement of lectin-, integrin-, and phosphatidylserine-mediated recognition. J. Neurochem. 75:2000;1060-1070.
52. Wu D.C., Jackson-Lewis V., Vila M., Tieu K., Teismann P., Vadseth C., Choi D.K., Ischiropoulos H., Przedborski S. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J. Neurosci. 22:2002;1763-1771.
53. Yu W.H., Go L., Guinn B.A., Fraser P.E., Westaway D., McLaurin J. Phenotypic and functional changes in glial cells as a function of age. Neurobiol. Aging. 23:2002;105-115.